Is Vectus Biosystems hiring right now?

Vectus Biosystems has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Vectus Biosystems's careers site.

Where is Vectus Biosystems headquartered?

Vectus Biosystems is headquartered in Australia and was founded in 2005.

Who leads Vectus Biosystems?

Tara Speranza, Chief Executive Officer, is at the top of Vectus Biosystems's org chart.

How do I apply for a job at Vectus Biosystems?

Pick a role on Vectus Biosystems's TheJobsMap page and select Apply. Every listing links to the original posting on Vectus Biosystems's own careers site, so you apply directly with the employer.

Vectus Biosystems jobs and careers

Australia

As of October 24, 2026, Vectus Biosystems has no open roles listed.

vectusbiosystems.com.au LinkedIn @vectusbio

About Vectus Biosystems

Vectus Biosystems Limited (ASX:VBS) is developing a treatment for fibrosis and high blood pressure, which includes the treatment for three of the largest diseases in the fibrotic market, namely heart, kidney and liver diseases. Vectus successfully completed its Initial Public Offering (IPO) on the Australian Securities Exchange (ASX:VBS) and commenced trading on ASX on 23 February 2016, after raising A$5.1 million. Funds from the IPO were predominantly used to develop the Company’s lead compound, VB0004, which aims to treat the hardening of functional tissue and high blood pressure. Vectus has conducted a range of successful pre-clinical trials, which have shown that VB0004 slows down the advances of fibrosis, potentially repairs damaged cell tissue and reduces high blood pressure. VB0004 is now progressing through a number of important milestones, including pharmaceutical scale-up and additional toxicity studies. Following successful results, the late 2019 convertible note fundraising, and the late 2020 share placement, the Company has funding for its Human Phase I trial. Vectus’ strategy is to develop and perform early validation of its drug candidates to the point where they may become commercially attractive to potential pharmaceutical partners. The Company has also developed technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The technology, called Accugen, is owned by Vectus’ wholly-owned subsidiary Accugen Pty Limited. The technology offers a time, cost and accuracy benefit compared to currently-available systems. The Company’s current stage of investment in Accugen is a commercialisation programme that may include direct sales, distribution partnerships and licensing opportunities.

Founded in 2005 by Karen Duggan.

Biotechnology

Founded: 2005
Employees: 1 to 10
Headquarters: Australia

Leadership

The top of Vectus Biosystems's org chart, with how many people report into each leader.

Tara Speranza

Chief Executive Officer

Jobs at Vectus Biosystems

No open positions right now. Explore more companies on TheJobsMap.

Vectus Biosystems jobs: common questions

Is Vectus Biosystems hiring right now?: Vectus Biosystems has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Vectus Biosystems's careers site.
Where is Vectus Biosystems headquartered?: Vectus Biosystems is headquartered in Australia and was founded in 2005.
Who leads Vectus Biosystems?: Tara Speranza, Chief Executive Officer, is at the top of Vectus Biosystems's org chart.
How do I apply for a job at Vectus Biosystems?: Pick a role on Vectus Biosystems's TheJobsMap page and select Apply. Every listing links to the original posting on Vectus Biosystems's own careers site, so you apply directly with the employer.